CVS Generic Drugs Suit Fails to Get Class Action California judge blocks 11 classes in suit that claims CVS charged insurers and insured patients more than uninsured patients. Rite Aid, Albertsons Expand Naloxone Access February 28, 2017 By Christine Blank Rite Aid and Albertsons expand naloxone Access, hoping to curb the opioid epidemic. Walgreens faces anti-tobacco effort ahead of annual meeting January 09, 2017 By Christine Blank Two organizations opposed to tobacco sales at pharmacy chains are turning their attention to Walgreens’ annual shareholder meeting on January 26. Report: Pharmacists dispensing dangerous drug combos January 09, 2017 By Christine Blank Walgreens, CVS Health and other drug chains promised to improve procedures after a Chicago Tribune investigation found that pharmacists at several retail chains filled prescriptions with dangerous drug combinations. Analyst: CVS’ OptumRx deal amps up competition December 06, 2016 By Christine Blank Last month, OptumRx and CVS Pharmacy announced that they are partnering to provide more convenient choices and lower costs for patients. Omnicare to pay $28 million for kickback scheme October 21, 2016 By Christine Blank Omnicare agreed to settle claims that it conspired with Abbott Laboratories “to engage in a number of disguised kickback arrangements to increase overall use of Depakote,” Walgreens expands 90-day pharmacy program offering October 10, 2016 By Anthony Vecchione The retail chain has linked itself with EnvisionRx. The Evolution of Group Purchasing Organizations October 10, 2016 By Valerie DeBenedette Somewhere in the United States, there may be a retail or specialty pharmacy that is not part of a group purchasing organization (GPO). If there is such a pharmacy, it is very hard to find. Battling DIR Fees October 06, 2016 By Christine Blank The profitability of both chain and independent pharmacies is being affected by direct and indirect remuneration fees that insurers are retroactively charging pharmacies after filling Medicare Part D prescriptions.